240 related articles for article (PubMed ID: 31474985)
1. Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency.
Munoz MA; Jurczyluk J; Simon A; Hissaria P; Arts RJW; Coman D; Boros C; Mehr S; Rogers MJ
Front Immunol; 2019; 10():1900. PubMed ID: 31474985
[TBL] [Abstract][Full Text] [Related]
2. Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases.
Jurczyluk J; Munoz MA; Skinner OP; Chai RC; Ali N; Palendira U; Quinn JM; Preston A; Tangye SG; Brown AJ; Argent E; Ziegler JB; Mehr S; Rogers MJ
Immunol Cell Biol; 2016 Nov; 94(10):994-999. PubMed ID: 27377765
[TBL] [Abstract][Full Text] [Related]
3. Increased core body temperature exacerbates defective protein prenylation in mouse models of mevalonate kinase deficiency.
Munoz MA; Skinner OP; Masle-Farquhar E; Jurczyluk J; Xiao Y; Fletcher EK; Kristianto E; Hodson MP; O'Donoghue SI; Kaur S; Brink R; Zahra DG; Deenick EK; Perry KA; Robertson AA; Mehr S; Hissaria P; Mulders-Manders CM; Simon A; Rogers MJ
J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 36189795
[TBL] [Abstract][Full Text] [Related]
4. Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency.
Politiek FA; Waterham HR
Front Immunol; 2021; 12():724991. PubMed ID: 34539662
[TBL] [Abstract][Full Text] [Related]
5. A possibly new autoinflammatory disease due to compound heterozygous phosphomevalonate kinase gene mutation.
Yıldız Ç; Gezgin Yıldırım D; Inci A; Tümer L; Cengiz Ergin FB; Sunar Yayla ENS; Esmeray Şenol P; Karaçayır N; Eğritaş Gürkan Ö; Okur I; Ezgü FS; Bakkaloğlu SA
Joint Bone Spine; 2023 Jan; 90(1):105490. PubMed ID: 36410683
[TBL] [Abstract][Full Text] [Related]
6. Defective protein prenylation is a diagnostic biomarker of mevalonate kinase deficiency.
Munoz MA; Jurczyluk J; Mehr S; Chai RC; Arts RJW; Sheu A; McMahon C; Center JR; Singh-Grewal D; Chaitow J; Campbell DE; Quinn JMW; Alexandrov K; Tnimov Z; Tangye SG; Simon A; Phan TG; Rogers MJ
J Allergy Clin Immunol; 2017 Sep; 140(3):873-875.e6. PubMed ID: 28501347
[No Abstract] [Full Text] [Related]
7. Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency.
Tricarico PM; Romeo A; Gratton R; Crovella S; Celsi F
Cell Physiol Biochem; 2017; 41(4):1649-1660. PubMed ID: 28359055
[TBL] [Abstract][Full Text] [Related]
8. Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report.
Omoyinmi E; Rowczenio D; Sebire N; Brogan PA; Eleftheriou D
Pediatr Rheumatol Online J; 2021 Nov; 19(1):161. PubMed ID: 34809655
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular consequences of mevalonate kinase deficiency.
Politiek FA; Turkenburg M; Henneman L; Ofman R; Waterham HR
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167177. PubMed ID: 38636615
[TBL] [Abstract][Full Text] [Related]
10. Identification of FDA-approved drugs that increase mevalonate kinase in hyper IgD syndrome.
Politiek FA; Turkenburg M; Koster J; Ofman R; Waterham HR
J Inherit Metab Dis; 2024 Mar; 47(2):302-316. PubMed ID: 38131282
[TBL] [Abstract][Full Text] [Related]
11. Unprenylated RhoA contributes to IL-1β hypersecretion in mevalonate kinase deficiency model through stimulation of Rac1 activity.
van der Burgh R; Pervolaraki K; Turkenburg M; Waterham HR; Frenkel J; Boes M
J Biol Chem; 2014 Oct; 289(40):27757-65. PubMed ID: 25107911
[TBL] [Abstract][Full Text] [Related]
12. A novel homozygous variant in PMVK is associated with enhanced IL1β secretion and a hyper-IgD syndrome-like phenotype.
Jairaman A; Badiger VA; Raj S; Nair KV; Balan S; Narayanan DL
Clin Genet; 2024 Mar; 105(3):302-307. PubMed ID: 38018277
[TBL] [Abstract][Full Text] [Related]
13. Quantification of mevalonate-5-phosphate using UPLC-MS/MS for determination of mevalonate kinase activity.
Reitzle L; Maier B; Stojanov S; Teupser D; Muntau AC; Vogeser M; Gersting SW
Clin Biochem; 2015 Aug; 48(12):781-7. PubMed ID: 25982894
[TBL] [Abstract][Full Text] [Related]
14. Mevalonate kinase-deficient THP-1 cells show a disease-characteristic pro-inflammatory phenotype.
Politiek FA; Turkenburg M; Ofman R; Waterham HR
Front Immunol; 2024; 15():1379220. PubMed ID: 38550596
[TBL] [Abstract][Full Text] [Related]
15. Analysis of NLRP3, MVK and TNFRSF1A variants in adult Greek patients with autoinflammatory symptoms.
Karagianni P; Nezos A; Ioakeim F; Tzioufas AG; Moutsopoulos HM
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):86-89. PubMed ID: 30418111
[TBL] [Abstract][Full Text] [Related]
16. A novel missense mutation in MVK associated with MK deficiency and dyserythropoietic anemia.
Samkari A; Borzutzky A; Fermo E; Treaba DO; Dedeoglu F; Altura RA
Pediatrics; 2010 Apr; 125(4):e964-8. PubMed ID: 20194276
[TBL] [Abstract][Full Text] [Related]
17. Mevalonate Kinase Deficiency as Cause of Periodic Fever in Two Siblings.
Correa ARE; Gupta N; Bagri N; Vignesh P; Alam S; Yamaguchi S
Indian Pediatr; 2020 Feb; 57(2):180-181. PubMed ID: 32060250
[TBL] [Abstract][Full Text] [Related]
18. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency.
Mandey SH; Schneiders MS; Koster J; Waterham HR
Hum Mutat; 2006 Aug; 27(8):796-802. PubMed ID: 16835861
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of clinical features and genetic variants in mevalonate kinase (MVK) gene of South Indian families suffering from Hyperimmunoglobulin D Syndrome.
Govindaraj GM; Jain A; Peethambaran G; Bhoyar RC; Vellarikkal SK; Ganapati A; Sandhya P; Edavazhippurath A; Dhanasooraj D; Puthenpurayil JM; Chakkiyar K; Mishra A; Batra A; Punnen A; Kumar S; Sivasubbu S; Scaria V
PLoS One; 2020; 15(8):e0237999. PubMed ID: 32822427
[TBL] [Abstract][Full Text] [Related]
20. MMAB, a novel candidate gene to be screened in the molecular diagnosis of Mevalonate Kinase Deficiency.
Mezzavilla M; Moura RR; Celsi F; Tricarico PM; Crovella S
Rheumatol Int; 2018 Jan; 38(1):121-127. PubMed ID: 29234874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
